FDA Drug Recalls

Recalls / Class II

Class IID-1756-2015

Product

Testosterone Cypionate 220 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN

Affected lot / code info
All lots distributed between November 2014 and May 2015; 11242014@36, 5/23/2015; 12042014@53, 6/2/2015; 12222014@67, 6/20/2015; 02192015@5, 8/18/2015, 05042015@77, 10/31/2015; 05052015@54, 11/1/2015

Why it was recalled

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Recalling firm

Firm
The Compounding Pharmacy of America
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
6216 Highland Place Way Ste 101-A, Knoxville, Tennessee 37919-4068

Distribution

Quantity
138 ml
Distribution pattern
Nationwide

Timeline

Recall initiated
2015-06-02
FDA classified
2015-09-15
Posted by FDA
2015-09-23
Terminated
2016-02-10
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1756-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls